Rather & Kittrell, Inc. Astrazeneca PLC Transaction History
Rather & Kittrell, Inc.
- $321 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,269Shares Held
483MCall Options Held
5.99MPut Options Held
5.22M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.82 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.87 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.38 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.72 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.36 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $244B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...